How does Sitagliptin impact the progression of diabetes-related kidney diseases, particularly in preserving renal function?
Sunil JoshiExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Sitagliptin, a DPP-4 inhibitor, may slow the progression of diabetic nephropathy by reducing albuminuria and improving glycemic control, thus potentially preserving renal function.